Fundz

Cyto Agents, Inc. reported raising $6.11 Million in an initial SEC Form D filing, from an offering of $6.5 Million

PRIVATEAug 12, 2021$6.1M of $6.5M raised

Amount Raised

$6.11 Million

$6.11 Million sold, per SEC Form D (first sale Aug 12, 2021)

Round Type

Venture

PittsburghBiotechnology

Quick answer

CytoAgents raised $6.11 Million in a funding round, dated August 12, 2021. CytoAgents is based in Pittsburgh, Pennsylvania, United States.

How much did CytoAgents raise?
CytoAgents raised $6.11 Million in a funding round on August 12, 2021.
What does CytoAgents do?
CytoAgents, Inc. is a clinical-stage therapeutics company developing CTO1681, an oral, steroid sparing immunomodulator for multiple indications driven by cytokine inducing inflammation.
Where is CytoAgents based and how big is it?
CytoAgents is based in Pittsburgh, Pennsylvania, United States. Fundz records about 10 employees.
Who are the decision-makers at CytoAgents?
Fundz holds 1 contact at CytoAgents, including the Director. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as CytoAgents that raised within 45 days of this round, from Fundz verified event records.

  • VITROLABS INC raised $22M on September 24, 2021.
  • Garuda Therapeutics raised $48M on September 24, 2021.
  • NANO-C raised $8.5M on September 24, 2021.
  • Aurora Bio, Inc. raised $117M on September 24, 2021.
  • GenEdit raised an undisclosed amount (Series A) on September 23, 2021.
  • PhenoBiome raised an undisclosed amount (Funding Round) on September 23, 2021.

Who to call at CytoAgents, and when

A new round usually means CytoAgents is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day CytoAgents raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at CytoAgents, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at CytoAgents. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

CytoAgents

Location

Alloy 26, 100 S. Commons, Suite 102

Pittsburgh, Pennsylvania, United States

About

CytoAgents, Inc. is a clinical-stage therapeutics company developing CTO1681, an oral, steroid sparing immunomodulator for multiple indications driven by cytokine inducing inflammation. By effectively reducing the inflammation in the tumor microenvironment and preventing life-threatening toxicities caused by overwhelming inflammation, CytoAgents is working to enable safer, widescale adoption of these breakthrough therapies. CTO1681 is currently in Phase 1b/2a for oncology patients receiving CAR T-Cell Therapy with plans to expand into additional therapeutic categories including asthma, COPD, and atopic dermatitis.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment CytoAgents raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsRoy P., DirectorSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for CytoAgents's next move

See what Strategic adds

CytoAgents raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.